Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
I am looking for
added new label for I am looking for
Advanced Filters
Found 134 clinical trials
Long-Term Respiratory Muscle Strength in Young COVID-19 Patients

therefore presents a variety of symptoms in the acute phase, such as fever, dry cough, fatigue, sore throat, loss of taste or smell, shortness of breath, nasal congestion, chest pain, muscle or joint pain

Accepts healthy volunteers
  • 08 Jul, 2022
  • 1 location
Neurological Outcome After SARS-CoV-2 Infection

manifestations vary in prevalence rates (6-84%) and range from mild (headache, hyposmia, myalgia) to severe (encephalopathy, strokes, seizures). Little is known about long-term neurological outcomes of COVID-19

  • 01 Sep, 2021
  • 1 location
Predictive Immune Biomarkers of COVID-19 Pathogenesis to Influence Therapeutic Management (IMMUNOMARKCOV)

Persons infected with Severe Acute Respiratory Syndrome (SARS) SARS-CoV-2 vary in severity from being asymptomatic to having fever, cough, sore throat, general weakness and fatigue and muscular

  • 05 Apr, 2022
  • 2 locations
Long COVID19 Fatigue and Obstructive Sleep Apnoea (PostCov2OSA)

Identify the relationship of obstructive sleep apnea (OSA) prevalence with post-COVID19 fatigue that remains at least six months after acute disease

  • 07 Apr, 2022
  • 10 locations
Can Patient Expectations Influence Pain Reduction After Epidural Injections in Patients With Low Back Pain?

We hypothesize that patients with higher expectations regarding their epidural injection experience a higher pain reduction of their lower back pain and/or leg pain after an epidural injection. Patients' expectations of an epidural injection can influence their level of pain reduction. The primary objective of this study is to investigate …

  • 19 Jun, 2022
The Impact of Covid-19 on Skeletal Muscle

With the recent worldwide outbreak of the COVID-19 infection and the huge impact it has had upon lives in the UK, it is key to increase knowledge on the impact of the virus on the body. Certain aspects of the virus' characteristics are also poorly understood: The reason behind the …

  • 11 Jul, 2021
  • 1 location
Kidney in Coronavirus Disease 2019 Registry (KidneyCOVID19)

The SARS-CoV-2 virus is a virus newly identified in January 2020. The WHO defined COVID-19 as a health emergency of international importance. The clinical manifestation of the COVID-19 disease cannot be fully described in the short time. First insights in patients suffering from acute kidney injury (AKI) during COVID-19 indicate …

  • 02 Jun, 2022
  • 1 location
COVID-19 in Pediatric Oncology and Hematology Centers in France

Since the description of the first cases of infection in December 2019 in the Hubei province in China, a new coronavirus, called SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2), emerged and caused a pandemic. This new virus is responsible for an infectious disease with respiratory and potent severe symptoms, called …

targeted therapy
coronavirus infection
primary cancer
  • 25 Jan, 2021
  • 1 location
Glucocorticoid Withdrawal Syndrome in Patients With Treated Cushing Syndrome

Cushing syndrome (CS) is an endocrine disorder caused by chronic exposure to glucocorticoid (GC) excess. Endogenous CS has an estimated incidence of 0.2 to 5.0 cases per million per year and prevalence of 39 to 79 cases per million in various populations. CS usually affects young women, with a median …

  • 02 Nov, 2021
  • 1 location
The Clinical Course of Interstitial Pneumonia With Autoimmune Features

Interstitial pneumonia with autoimmune features (IPAF) is a chronic interstitial lung disease (ILD) with some laboratoristic and/or clinical features of autoimmune disease, but without meeting criteria of connective tissue disease (CTD), and with no other causes of ILD. Despite recent efforts to standardize the diagnosis of IPAF, subjects with IPAF …

lung transplant
  • 20 Apr, 2022
  • 1 location